Risk of prostate cancer is not affected by prediagnosis sex-hormone levels
This article has no abstract so we have provided the first paragraph of the full text.
Studies that examine the effects of circulating endogenous sex hormones on the risk of prostate cancer have yielded mixed results: some indicate modest associations, but most are insufficiently powered to supply robust conclusions. The Endogenous Hormones and Prostate Cancer Collaborative Group performed a pooled analysis of 18 prospective studies, with the aim of uniformly assessing the association between serum levels of various sex hormones and risk of prostate cancer.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.